How does a biotech company decide what to work on? How does a company advance its pipeline? How does a company formulate a partnering strategy? Who is involved in these processes?

In this interactive event, industry professionals working in business development, strategy, operations, and corporate development at cutting-edge Bay Area therapeutics companies will address these questions. The panelists include:

• Serra Elliot, PhD – BlueLight Therapeutics
• Ben Cohn, MS – Myokardia
• Matthew Cook, PhD – Gilead Sciences
• Sandy Mong, MD – BridgeBio Pharma
• Zaneta Ordowaz, PhD – Amunix Pharmaceuticals
• Tyler Chavez, PhD – Beigene
• Moderated by Marcela Preininger – BCBA President

Join event virtually via Zoom: https://us02web.zoom.us/j/84239649006

If you have questions for the panelists, submit them here: https://bit.ly/BCBABTC